Related Funds
| Fund Name | Location |
| Accanto Partners | Belvedere Tiburon, California, United States |
| ALIVE Israel HealthTech Fund | Israel, Tel Aviv, Tel Aviv District |
| Bank of Hangzhou | China, Hangzhou, Zhejiang |
| Dong Fund | Beijing, Beijing, China |
| Entropy Research Lab | California, Carson, United States |
| Equus Total Return,Inc. | Houston, Texas, United States |
| Futaba | Japan, Yamanashi, Yamanashi Prefecture |
| Gaotong Touzi | China, Shanghai |
| Greenhill Capital Partners | New York, New York, United States |
| Orthofix, Inc | Lewisville, Texas, United States |
| Pivotal Ventures | Seattle, United States, Washington |
| Point72 Ventures | New York, New York, United States |
| Shaman Ventures | New York, New York, United States |
| Solis Capital Partners | California, Newport Beach, United States |
| T-Rex Capital | China, Guangdong, Guangzhou |
| TCS Capital Management | New York, New York, United States |
| Wille Finance | Switzerland, Zürich, Zurich |
| Wiretap Ventures | Colorado, Denver, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SAB Medical inc. | $119K | 01 Jan 2023 | Montréal, Quebec, Canada | ||
AIM Colours | $6M | 21 Sep 2022 | Montréal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SAB Medical inc. | $119K | 01 Jan 2023 | Montréal, Quebec, Canada | ||
AIM Colours | $6M | 21 Sep 2022 | Montréal, Quebec, Canada |
